Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Vascular endothelial growth factor receptors 1,3 and caveolin-1 are implicated in colorectal cancer aggressiveness and prognosis--correlations with epidermal growth factor receptor, CD44v6, focal adhesion kinase, and c-Met.

Garouniatis A, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG.

Tumour Biol. 2013 Aug;34(4):2109-17. doi: 10.1007/s13277-013-0776-1. Epub 2013 Apr 12. Erratum in: Tumour Biol. 2013 Aug;34(4):2119.

PMID:
23580180
2.

FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.

Garouniatis A, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou AG.

Int J Colorectal Dis. 2013 Jan;28(1):9-18. doi: 10.1007/s00384-012-1520-9. Epub 2012 Jun 26.

PMID:
22733437
3.

Prognostic significance of epidermal growth factor receptor and vascular endothelial growth factor receptor in colorectal adenocarcinoma.

Kim JY, Bae BN, Kwon JE, Kim HJ, Park K.

APMIS. 2011 Jul;119(7):449-59. doi: 10.1111/j.1600-0463.2011.02752.x. Epub 2011 Apr 25.

PMID:
21635552
4.

Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.

Martins SF, Garcia EA, Luz MA, Pardal F, Rodrigues M, Filho AL.

Cancer Genomics Proteomics. 2013 Mar-Apr;10(2):55-67.

PMID:
23603341
5.

Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.

Abajo A, Bitarte N, Zarate R, Boni V, Lopez I, Gonzalez-Huarriz M, Rodriguez J, Bandres E, Garcia-Foncillas J.

World J Gastroenterol. 2012 Feb 21;18(7):637-45. doi: 10.3748/wjg.v18.i7.637.

6.

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.

Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.

PMID:
12553021
7.
8.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
9.

Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.

Okita NT, Yamada Y, Takahari D, Hirashima Y, Matsubara J, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T.

Jpn J Clin Oncol. 2009 Sep;39(9):595-600. doi: 10.1093/jjco/hyp066. Epub 2009 Jun 17.

PMID:
19535387
10.

Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.

Jayasinghe C, Simiantonaki N, Michel-Schmidt R, Kirkpatrick CJ.

Oncol Rep. 2009 Nov;22(5):1093-100.

PMID:
19787226
11.

Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.

White JD, Hewett PW, Kosuge D, McCulloch T, Enholm BC, Carmichael J, Murray JC.

Cancer Res. 2002 Mar 15;62(6):1669-75.

12.

Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling.

Matzke-Ogi A, Jannasch K, Shatirishvili M, Fuchs B, Chiblak S, Morton J, Tawk B, Lindner T, Sansom O, Alves F, Warth A, Schwager C, Mier W, Kleeff J, Ponta H, Abdollahi A, Orian-Rousseau V.

Gastroenterology. 2016 Feb;150(2):513-25.e10. doi: 10.1053/j.gastro.2015.10.020. Epub 2015 Oct 24.

PMID:
26597578
13.

[Correlation of lymphangiogenesis to progression of colorectal cancer].

Wang TB, Huang YH, Lan P, Song XM, Wang JP.

Ai Zheng. 2005 Oct;24(10):1276-9. Chinese.

PMID:
16219148
15.

[Expression of molecular markers detected by immunohistochemistry and risk of lymph node metastasis in stage T1 and T2 colorecrectal cancers].

Wang FL, Wan DS, Lu ZH, Fang YJ, Li LR, Chen G, Wu XJ, Ding PR, Kong LH, Lin JZ, Pan ZZ.

Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):277-81. doi: 10.3760/cma.j.issn.0253-3766.2013.04.008. Chinese.

PMID:
23985256
16.

Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer.

Karamitopoulou E, Zlobec I, Panayiotides I, Patsouris ES, Peros G, Rallis G, Lapas C, Karakitsos P, Terracciano LM, Lugli A.

Hum Pathol. 2011 Dec;42(12):1888-96. doi: 10.1016/j.humpath.2010.06.020. Epub 2011 Jun 12.

PMID:
21664646
17.

Combined preoperative CEA and CD44v6 improves prognostic value in patients with stage I and stage II colorectal cancer.

Chen L, Jiang B, Wang Z, Liu M, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Cui M, Su X.

Clin Transl Oncol. 2014 Mar;16(3):285-92. doi: 10.1007/s12094-013-1069-2. Epub 2013 Jul 17.

PMID:
23860725
19.

Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer?

Inno A, Di Salvatore M, Cenci T, Martini M, Orlandi A, Strippoli A, Ferrara AM, Bagalà C, Cassano A, Larocca LM, Barone C.

Clin Colorectal Cancer. 2011 Dec;10(4):325-32. doi: 10.1016/j.clcc.2011.03.028. Epub 2011 May 11.

PMID:
21729677
20.

Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.

Yonemori K, Tsuta K, Ando M, Hirakawa A, Hatanaka Y, Matsuno Y, Chuman H, Yamazaki N, Fujiwara Y, Hasegawa T.

Ann Surg Oncol. 2011 Oct;18(10):2841-50. doi: 10.1245/s10434-011-1640-4. Epub 2011 Mar 16.

PMID:
21409488

Supplemental Content

Support Center